Loss of Golga7 in adult mice effectively suppresses NrasG12D‐driven myeloproliferative neoplasm by disrupting its PM localization and impairing subsequent MAPK signaling, without affecting normal hematopoiesis or causing detectable toxicity, although it leads to embryo lethality. The gene discussed is GOLGA7; the disease is myeloproliferative disorder.